LATEST
Penta Fine Ingredients acquired SynerzineHexagon agreed to acquire RocscienceSRS Acquiom / PantaraiSpaceX agreed to acquire nationwide 800 MHz spectrum portfolioAEA Investors acquired RensaWittington Investments agreed to acquire BootsEurazeo / MIYA Water: majority stakeMiddle River Power acquired Panoche Energy CenterAltaris acquired Life Sciences & HealthcareAltaris acquired Simulations PlusCD&R agreed to acquire Option Care HealthKKR agreed to acquire Gen II Fund Services
Open App
ClosedPublished 6 Oct 2026

Altaris /
Life Sciences & Healthcare

Altaris completes purchase of Clarivate's Life Sciences & Healthcare segment

Buy side: Altaris
Buy sideAltaris
Target: Clarivate
TargetClarivate
Clarivate Plc (SEC EDGAR Form 8-K Exhibit 99.1) · 6 Oct 2026Source
See the source
Follow Altaris Follow Life Sciences & Healthcare
Buy side: Altaris
Buy sideAltaris
Target: Clarivate
TargetClarivate
01 / BuyerAltaris
02 / SellerClarivate
03 / TargetLife Sciences & Healthcare
Source for the buyer, seller and target: Clarivate Plc (SEC EDGAR Form 8-K Exhibit 99.1)

For the buyer, seller and target.

“Clarivate Plc (NYSE: CLVT) ("Clarivate" or the "Company"), a leading global provider of transformative intelligence, today announced the successful completion of the sale of its Life Sciences & Healthcare segment to Altaris, LLC (“Altaris”), advancing Clarivate’s transformation and simplifying its portfolio.”

Published 6 Oct 2026

Open the source
01

What happened

Clarivate Plc completed the sale of its Life Sciences & Healthcare segment to Altaris, LLC, Clarivate said on October 6, 2026. The transaction for $600 million was first announced on July 6, 2026. [01]

Clarivate plans to use the proceeds to reduce debt and will focus on its Academia & Government and Intellectual Property segments. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · Clarivate Plc (SEC EDGAR Form 8-K Exhibit 99.1)

Altaris completes purchase of Clarivate's Life Sciences & Healthcare segment

This document is the source for the companies, stage, figure and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Announced

    “The transaction for $600 million was first announced on July 6, 2026”

    Open the source

  2. Announced

    “Altaris completes purchase of Clarivate's Life Sciences & Healthcare segment Clarivate Plc completed the sale of its Life Sciences & Healthcare segment to Altaris, LLC, Clarivate said on October 6, 2026”

    Open the source

  3. Published by Clarivate Plc (SEC EDGAR Form 8-K Exhibit 99.1)

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.

04

Deal Web

Every firm and person on this deal, and how they connect. Open any name to see their other deals.

Deal Web · 3 firms · 0 peopleHover a name to see how it connects
This dealAltaris / Life Sciences & HealthcareClosed · Published 6 Oct 2026
BuyerAltarisTargetLife Sciences & HealthcareSellerClarivate
This dealAltaris / Life Sciences & Healthcare

Closed · Altaris acquired Life Sciences & Healthcare from Clarivate (Closed, published 6 Oct 2026).

Announced 6 Jul 2026
Timeline
  1. Announced
  2. Announced
  3. Published by Clarivate Plc (SEC EDGAR Form 8-K Exhibit 99.1)
Hover or tap a name to see how it connects, and when
Deal Web as a list
  • Altaris (Buyer) acquired this deal. Altaris: 2 deals on Carrywatch.
  • Life Sciences & Healthcare (Target) target this deal. Life Sciences & Healthcare: 1 deal on Carrywatch.
  • Clarivate (Seller) sold this deal. Clarivate: 1 deal on Carrywatch.